Mhairi Skinner drafts and prosecutes patent applications relating to biotechnology and pharmacology among other technical fields. A patent agent in the Ottawa office of Borden Ladner Gervais LLP, she is a member of the Intellectual Property Group. Mhairi also conducts IP due diligence searches and provides freedom-to-operate opinions.
Following graduate school, Mhairi co-founded a biotechnology company in the area of cancer therapeutics. She has previously worked as an editor at Nature Publishing Group, as a consultant to the National Institute of Health (National Cancer Institute) and as an Adjunct Professor at the University of Guelph. She has conducted research in the areas of biochemistry, cell and molecular biology, bioinformatics, and genetics. Mhairi is fluent in both English and French.